In view of the implications of B cells in the mechanism of action of this cytokine [21], it is reasonable to hypothesize that HCMV infection in MS patients may modulate the influence of IFNβ on B cell differentiation. The gene discussed is IFNB1; the disease is cytomegalovirus infection.